June 3, 2019
FSD Pharma Names Raza Bokhari, M.D. as Permanent CEO
Company Also Reports Q1 2019 Financial Results TORONTO–(BUSINESS WIRE)–#FSDDF–The Board of Directors of FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF)…
Pharmaceuticals, Biotechnology and Life Sciences
Company Also Reports Q1 2019 Financial Results TORONTO–(BUSINESS WIRE)–#FSDDF–The Board of Directors of FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF)…
Data Presented at European Academy of Allergy and Clinical Immunology Congress OSAKA, Japan–(BUSINESS WIRE)–Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today…
Ablexis grants rights to use the AlivaMab™ Mouse platform for research, development and potential commercialization of antibodies SAN DIEGO–(BUSINESS WIRE)–Ablexis,…
Phase III study protocol for Namodenoson in the treatment of advanced liver cancer patients is now being prepared and will…
The world’s premier life sciences event returns to Philadelphia for four days of inspiring keynote speeches, fireside chats and educational…
CHICAGO & CAMBRIDGE, Mass.–(BUSINESS WIRE)–#AANAM–Exicure, Inc. (OTCQB: XCUR), the pioneer in gene regulatory and immunotherapeutic drugs utilizing spherical nucleic acid…
Opdivo plus Yervoy yielded objective response rate of 31% and median duration of response of 17.5 months Data demonstrate potential…
New Clinical Data Presented Today Included in Recently Submitted NDA to FDA CAMBRIDGE, Mass.–(BUSINESS WIRE)–Epizyme, Inc. (Nasdaq: EPZM), a late-stage…
STAMFORD, Conn.–(BUSINESS WIRE)–SpringWorks Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing life-changing medicines for patients with severe rare diseases…
NEW YORK–(BUSINESS WIRE)–#ChildhoodCancerAwareness–Massive Bio, Inc., a leader in precision medicine and patient centric clinical trial matching, announces today its partnership…